Search by Drug Name or NDC
NDC 00121-1760-30 Mag-AL Liquid 200; 200 mg/5mL; mg/5mL Details
Mag-AL Liquid 200; 200 mg/5mL; mg/5mL
Mag-AL Liquid is a ORAL SUSPENSION in the HUMAN OTC DRUG category. It is labeled and distributed by PAI Holdings, LLC. The primary component is ALUMINUM HYDROXIDE; MAGNESIUM HYDROXIDE.
MedlinePlus Drug Summary
Aluminum Hydroxide, Magnesium Hydroxide are antacids used together to relieve heartburn, acid indigestion, and upset stomach. They may be used to treat these symptoms in patients with peptic ulcer, gastritis, esophagitis, hiatal hernia, or too much acid in the stomach (gastric hyperacidity). They combine with stomach acid and neutralize it. Aluminum Hydroxide, Magnesium Hydroxide are available without a prescription. This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.
Related Packages: 00121-1760-30Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Aluminum Hydroxide and Magnesium Hydroxide
Product Information
| NDC | 00121-1760 |
|---|---|
| Product ID | 0121-1760_e499949c-ef7f-4dd3-927d-b069e0625e82 |
| Associated GPIs | 48990002101815 |
| GCN Sequence Number | 011796 |
| GCN Sequence Number Description | magnesium, aluminum hydroxide ORAL SUSP 200-200/5 ORAL |
| HIC3 | D4B |
| HIC3 Description | ANTACIDS |
| GCN | 63980 |
| HICL Sequence Number | 001169 |
| HICL Sequence Number Description | MAGNESIUM HYDROXIDE/ALUMINUM HYDROXIDE |
| Brand/Generic | Brand |
| Proprietary Name | Mag-AL Liquid |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Aluminum Hydroxide and Magnesium Hydroxide |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | SUSPENSION |
| Route | ORAL |
| Active Ingredient Strength | 200; 200 |
| Active Ingredient Units | mg/5mL; mg/5mL |
| Substance Name | ALUMINUM HYDROXIDE; MAGNESIUM HYDROXIDE |
| Labeler Name | PAI Holdings, LLC |
| Pharmaceutical Class | Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH FINAL |
| Application Number | part331 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00121-1760-30 (00121176030)
| NDC Package Code | 0121-1760-30 |
|---|---|
| Billing NDC | 00121176030 |
| Package | 10 TRAY in 1 CASE (0121-1760-30) / 10 CUP, UNIT-DOSE in 1 TRAY / 30 mL in 1 CUP, UNIT-DOSE |
| Marketing Start Date | 2004-01-14 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |